These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38519890)

  • 21. The ganglioside G
    Balis FM; Busch CM; Desai AV; Hibbitts E; Naranjo A; Bagatell R; Irwin M; Fox E
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28031. PubMed ID: 31612589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical features of neuroblastoma: an analysis of 44 children].
    Zhu CG; He XL; Tang ZG; Chen KK; Zou RY; Tian X; You YL
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1193-1197. PubMed ID: 33172554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A signature of 29 immune-related genes pairs to predict prognosis in patients with neuroblastoma.
    Song J; Zhao Q; Xu Y; Zhu L
    Int Immunopharmacol; 2020 Nov; 88():106994. PubMed ID: 33182060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
    Naranjo A; Irwin MS; Hogarty MD; Cohn SL; Park JR; London WB
    JCO Clin Cancer Inform; 2018 Dec; 2():1-15. PubMed ID: 30652588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and significance of programmed cell death ligand-1 in neuroblastoma tissues].
    Liao R; Sun XF; Zhen ZZ; Huang DS
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):735-740. PubMed ID: 30293276
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.
    Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC
    Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis.
    Li C; Lu X; Zhang F; Huang S; Ding L; Wang H; Chen S
    BMC Cancer; 2024 Sep; 24(1):1151. PubMed ID: 39289658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Validation of Inflammatory Response-Related Gene Signatures to Predict the Prognosis of Neuroblastoma.
    Song J; Song L; Lv Z; Liu J; Feng X; Zhang S; Song A
    Int J Genomics; 2022; 2022():2417351. PubMed ID: 35535346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients.
    Wang J; Meng X; Chen K; Feng J
    Front Oncol; 2022; 12():1014845. PubMed ID: 36530992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors of Recurrence After Complete Response in Children with Neuroblastoma: A 16-Year Retrospective Study of 179 Cases.
    Li F; Zhang W; Hu H; Zhang Y; Li J; Huang D
    Cancer Manag Res; 2022; 14():107-122. PubMed ID: 35023974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals.
    Wu R; Li X; Chen Z; Shao Q; Zhang X; Tang W; Hu B
    BMC Pediatr; 2023 Aug; 23(1):426. PubMed ID: 37633889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma.
    Su Y; Wang L; Wang X; Yue Z; Xing T; Zhao W; Zhao Q; Duan C; Huang C; Han Y; Qiu L; Cheng X; Liu Y; Ma X
    Cancer Med; 2019 Apr; 8(4):1558-1566. PubMed ID: 30793512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report.
    Pinto N; Naranjo A; Ding X; Zhang FF; Hibbitts E; Kennedy R; Tibbetts R; Wong-Michalak S; Craig DW; Manojlovic Z; Hogarty MD; Kreissman S; Bagatell R; Irwin MS; Park JR; Asgharzadeh S
    Clin Cancer Res; 2023 Apr; 29(8):1546-1556. PubMed ID: 36749880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
    Castleberry RP; Shuster JJ; Smith EI
    J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical characteristics and prognostic analyses of cervical neuroblastoma].
    Liu QY; Wang SC; Jin YQ; Chu P; Guo YL; Ma XL; Su Y; Zhang J; Li YZ; Zhang XX; Sun N; Liu ZY; Ni X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 57(6):711-717. PubMed ID: 35725314
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroblastoma in adolescents: genetic and clinical characterisation.
    Castel V; Villamón E; Cañete A; Navarro S; Ruiz A; Melero C; Herrero A; Yáñez Y; Noguera R
    Clin Transl Oncol; 2010 Jan; 12(1):49-54. PubMed ID: 20080471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
    Haase GM; Atkinson JB; Stram DO; Lukens JN; Matthay KK
    J Pediatr Surg; 1995 Feb; 30(2):289-94; discussion 295. PubMed ID: 7738753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor dormancy is closely related to prognosis prediction and tumor immunity in neuroblastoma.
    Tian X; Cao F; Li X; He Y; Xia Y; Chen L; Zhao Q
    Transl Pediatr; 2023 Mar; 12(3):445-461. PubMed ID: 37035400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
    Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
    BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.